- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
October 18, 2016 – Joanna Dobos is the mother of 4 sons who have severe eczema. While her children face various challenges in managing their eczema symptoms, she has also focused on their self-esteem. “It is very important to help my boys learn to accept themselves,” she said. Last spring her youngest son asked her to […]
A recent survey conducted by the National Eczema Association (NEA) in early September revealed at more than 20% of parents and caregivers who responded indicated their children experienced bullying at school, during extracurricular activities or with friends because of eczema. The Dermatology Times highlighted this difficult problem in a recent article, Survey puts spotlight on […]
Los Angeles, CA – On Sunday, October 2, 2016 the National Eczema Association (NEA) kicks-off Eczema Awareness Month with their sixth Itching for a Cure fundraising walk. This year’s walk will be held on the campus of the University of California, Los Angeles (UCLA), and seeks to raise more than $75,000 to build eczema awareness […]
PRESS RELEASE One in five children with eczema will be bullied this school year due to their disease, according to the National Eczema Association San Rafael, California, September 7, 2016 – Results from a new National Eczema Association (NEA) survey of eczema parents and caregivers show that at least one in five children with eczema, including […]
What you need to know Finding a treatment that works for your eczema or atopic dermatitis (AD) symptoms can feel like an endless cycle for some people. And it’s not just about finding the right medicine, but about getting it covered by your health plan as well. It’s hard enough when your eczema is flaring; […]
Understanding AD’s impact to improve your quality of life People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and inflammation –they also include […]
Eczema affects more than 30 million people in the United States. The most common and chronic form of eczema is known as atopic dermatitis (AD). There is currently no cure for eczema or AD. To help raise awareness about the serious impact AD has on individuals and families, the National Eczema Association (NEA) has joined […]
We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]
June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).
February 11, 2016 – Late last month, NEA’s Board of Directors gathered together for the annual NEA Board retreat in San Francisco, California. This year’s retreat focused on both celebrating 2015 successes, and sharing a number of exciting 2016 initiatives that will advance NEA’s Roadmap strategic plan goals.